Article
CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness.
Leukemia - 1 Dec 2025
Romero-Moya Damia, Torralba-Sales Eric, Calvo Cristina, Marin-Bejar Oskar, Magallon-Mosella Maria, Distefano Maximiliano, Pera Joan, Castaño Julio, De Giorgio Francesca, Gonzalez Jessica, Iglesias Arnau, Berenguer-Balaguer Clara, Schilling Marcel, Plass Mireya, Pasquali Lorenzo, Català Albert, Molina Oscar, Wlodarski Marcin W, Bigas Anna, Giorgetti Alessandra
Abstract excerpt
GATA2 deficiency is a monogenic transcriptopathy disorder characterized by bone marrow failure (BMF), immunodeficiency, and a high risk of developing myelodysplastic neoplasms (MDS) and acute myeloid leukemia (AML). Although informative mouse models have been developed, the mechanisms by which GATA2 haploinsufficiency drives disease initiation in humans remain incompletely understood. To address this, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
